A randomized, phase 1, placebo‐controlled trial of APG‐157 in oral cancer demonstrates systemic absorption and an inhibitory effect on cytokines and tumor‐associated microbes
Published 2020 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
A randomized, phase 1, placebo‐controlled trial of APG‐157 in oral cancer demonstrates systemic absorption and an inhibitory effect on cytokines and tumor‐associated microbes
Authors
Keywords
-
Journal
CANCER
Volume -, Issue -, Pages -
Publisher
Wiley
Online
2020-02-05
DOI
10.1002/cncr.32644
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Cancer statistics, 2019
- (2019) Rebecca L. Siegel et al. CA-A CANCER JOURNAL FOR CLINICIANS
- Curcumin Nanoformulations for Colorectal Cancer: A Review
- (2019) Kar En Wong et al. Frontiers in Pharmacology
- Nivolumab vs investigator’s choice in recurrent or metastatic squamous cell carcinoma of the head and neck: 2-year long-term survival update of CheckMate 141 with analyses by tumor PD-L1 expression
- (2018) Robert L. Ferris et al. ORAL ONCOLOGY
- Compositional and functional variations of oral microbiota associated with the mutational changes in oral cancer
- (2018) Shun-Fa Yang et al. ORAL ONCOLOGY
- Oral Microbiota Community Dynamics Associated With Oral Squamous Cell Carcinoma Staging
- (2018) Chia-Yu Yang et al. Frontiers in Microbiology
- Association of Oral Microbiome With Risk for Incident Head and Neck Squamous Cell Cancer
- (2018) Richard B. Hayes et al. JAMA Oncology
- Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries
- (2018) Freddie Bray et al. CA-A CANCER JOURNAL FOR CLINICIANS
- The Performance of an Oral Microbiome Biomarker Panel in Predicting Oral Cavity and Oropharyngeal Cancers
- (2018) Yenkai Lim et al. Frontiers in Cellular and Infection Microbiology
- Immune Checkpoint Inhibition in Head and Neck Cancer
- (2018) Martin David Forster et al. Frontiers in Oncology
- Pembrolizumab versus methotrexate, docetaxel, or cetuximab for recurrent or metastatic head-and-neck squamous cell carcinoma (KEYNOTE-040): a randomised, open-label, phase 3 study
- (2018) Ezra E W Cohen et al. LANCET
- Curcumin gum formulation for prevention of oral cavity head and neck squamous cell carcinoma
- (2018) Lindsay Boven et al. LARYNGOSCOPE
- Curcumin as a clinically-promising anti-cancer agent: pharmacokinetics and drug interactions
- (2017) Jeffry Adiwidjaja et al. Expert Opinion on Drug Metabolism & Toxicology
- The Essential Medicinal Chemistry of Curcumin
- (2017) Kathryn M. Nelson et al. JOURNAL OF MEDICINAL CHEMISTRY
- Colonization with enterotoxigenic Bacteroides fragilis is associated with early-stage colorectal neoplasia
- (2017) Rachel V. Purcell et al. PLoS One
- Indicators of responsiveness to immune checkpoint inhibitors
- (2017) Bradley D. Shields et al. Scientific Reports
- Bacterial alterations in salivary microbiota and their association in oral cancer
- (2017) Wei-Hsiang Lee et al. Scientific Reports
- Anticancer Activity of Curcumin and Its Analogues: Preclinical and Clinical Studies
- (2016) Alessandro Allegra et al. CANCER INVESTIGATION
- Lipocalin 2 Protects from Inflammation and Tumorigenesis Associated with Gut Microbiota Alterations
- (2016) Alexander R. Moschen et al. Cell Host & Microbe
- A Novel Approach to High-Quality Postmortem Tissue Procurement: The GTEx Project
- (2015) Latarsha J. Carithers et al. BIOPRESERVATION AND BIOBANKING
- Combination cancer immunotherapies tailored to the tumour microenvironment
- (2015) Mark J. Smyth et al. Nature Reviews Clinical Oncology
- Releasing the Brakes on Cancer Immunotherapy
- (2015) Antoni Ribas NEW ENGLAND JOURNAL OF MEDICINE
- A Novel Approach to High-Quality Postmortem Tissue Procurement: The GTEx Project
- (2015) Latarsha J. Carithers et al. Biopreservation and Biobanking
- Liposome encapsulated curcumin-difluorinated (CDF) inhibits the growth of cisplatin resistant head and neck cancer stem cells
- (2015) Saroj K. Basak et al. Oncotarget
- Phase I study of weekly nab-paclitaxel + weekly cetuximab + intensity-modulated radiation therapy (IMRT) in patients with stage III–IVB head and neck squamous cell carcinoma (HNSCC)
- (2014) M. G. Fury et al. ANNALS OF ONCOLOGY
- p16 Protein and Gigaxonin Are Associated with the Ubiquitination of NFκB in Cisplatin-induced Senescence of Cancer Cells
- (2014) Mysore S. Veena et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Current Treatment Options for Metastatic Head and Neck Cancer
- (2012) Katharine A. R. Price et al. CURRENT TREATMENT OPTIONS IN ONCOLOGY
- Curcumin Treatment Suppresses IKKβ Kinase Activity of Salivary Cells of Patients with Head and Neck Cancer: A Pilot Study
- (2011) Suejung G. Kim et al. CLINICAL CANCER RESEARCH
- Curcumin: A review of anti-cancer properties and therapeutic activity in head and neck squamous cell carcinoma
- (2011) Reason Wilken et al. Molecular Cancer
- Potential applications of curcumin and its novel synthetic analogs and nanotechnology-based formulations in cancer prevention and therapy
- (2011) Murielle Mimeault et al. Chinese Medicine
- MicroRNA-related genetic variations as predictors for risk of second primary tumor and/or recurrence in patients with early-stage head and neck cancer
- (2010) Xiaofan Zhang et al. CARCINOGENESIS
- Curcumin Enhances the Effect of Cisplatin in Suppression of Head and Neck Squamous Cell Carcinoma via Inhibition of IKK Protein of the NF B Pathway
- (2010) V. M. Duarte et al. MOLECULAR CANCER THERAPEUTICS
- Oral microbiota and cancer
- (2010) Jukka H. Meurman Journal of Oral Microbiology
- Liposome-Encapsulated Curcumin Suppresses Growth of Head and Neck Squamous Cell Carcinoma In vitro and in Xenografts through the Inhibition of Nuclear Factor B by an AKT-Independent Pathway
- (2008) D. Wang et al. CLINICAL CANCER RESEARCH
- Phase II Trial of Curcumin in Patients with Advanced Pancreatic Cancer
- (2008) N. Dhillon et al. CLINICAL CANCER RESEARCH
- Pathways connecting inflammation and cancer
- (2008) Paola Allavena et al. CURRENT OPINION IN GENETICS & DEVELOPMENT
Become a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get StartedAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started